Vande Mataram Camp commences at Brainware University, West Bengal (See 'Corp Brief') Digitalization no longer a Choice, but Steel Sector's Survival Strategy: Kumaraswamy (See 'Corp Brief') IP 2026 establishes Standards for Blood and Blood Components (See 'Corp Brief') Ministry of Coal organises BRICS Side Event on Clean Coal Technologies (See 'Corp Brief') SEBI - Failure to file Quarterly Activity Reports for multiple consecutive quarters constitutes violation of regulatory framework & attracts consequences prescribed under Regulation 35 of AIF Regulations, 2012: SEBI (See 'Legal Desk') 100 Startups from 22 States complete Export-Focused Acceleration Programme (See 'Corp Brief') MoS pitches 'BRICS Space Economy' (See 'Corp Brief') IPC successfully conducts Training on Ethylene Glycol & DEG in Preparations by Gas Chromatography (See 'Corp Brief') Unlocking Potential of Idle Financial Assets in India (See 'Corp Brief') SARFAESI - In absence of any adjudication by the DRT in determining the debt, statutory scheme permits reliance upon claim made by secured creditor for purpose of fixing pre-deposit: HC (See 'Legal Desk') CCI okays acquisition of shares in Nxtra Data by Alpha Wave Ventures (See 'Corp Brief') CCI okays acquisition of 21% voting interest in Astemo Ltd. by Honda Motor (See 'Corp Brief') FEMA - Claims & liabilities pertaining to periods prior to approval of resolution plan, which do not survive under approved plan, are extinguished & cannot be enforced: SAFEMA (See 'Legal Desk') Special Drive launched for expeditious Disposal of Long-Pending Labour Cases (See 'Corp Brief') Amit Shah to launch NAFED's auction portal 'NAFEX.in' (See 'Corp Brief') SEBI - A judicial pronouncement cannot ordinarily be modified or reviewed through post-disposal miscellaneous application; Tribunal becomes functus officio upon disposal of appeal: SAT (See 'Legal Desk') Railways approves Kavach Deployment Worth Rs.270 Crore on East Coast (See 'Corp Brief') DIBD and AISF sign MoU to promote Language Technology and Multilingual Innovation in Assam (See 'Corp Brief') IPR - Injunction allowed as defendant's adoption of marks is not honest or bona fide; marks are deceptively similar to plaintiff's registered trademark, such that an average consumer with imperfect recollection would likely be confused: HC (See 'Legal Desk') NMDC accelerates Digitalisation and Sustainable Mining to support 100 MTPA Vision (See 'Corp Brief') Union Minister sanctions over 42,000 houses in MP; 38,000 families perform grih pravesh (See 'Corp Brief') A&C - Where a Section 34 court has already examined the award, a possible alternative interpretation of the contractual clause is insufficient to justify interference: HC (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT') Union Minister reviews Power Sector and Urban Development Schemes with Jharkhand Govt (See 'Corp Brief') APEDA facilitates First Export of fresh Uttarakhand Litchi to Italy (See 'Corp Brief') Trade Marks - Quasi-judicial authority cannot validly base its decision on grounds that were not specifically disclosed in SCN, thereby depriving noticee of an effective opportunity to respond: HC (See 'Legal Desk') Nadda calls for Push towards a TB-Free India (See 'Corp Brief') India must take control of security-related necessities to remain future-ready: RM (See 'Corp Brief') A&C - Financial hardship cannot justify payment of disputed amount linked to fulfilment of deliverable-based obligations: HC (See 'Legal Desk')

Print

IP 2026 establishes Standards for Blood and Blood Components

Published: Jun 25, 2026

By TIOLCorplaws News Service

NEW DELHI, JUN 25, 2026: THE Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health and Family Welfare, Government of India, organized a National Conference on "Ensuring Quality of Blood and Blood Components through IP 2026" at its campus in Ghaziabad on June 24, 2026, to facilitate awareness and implementation of the newly introduced blood and blood component monographs in the Indian Pharmacopoeia (IP) 2026.

The conference brought together over 160 participants, including blood centre professionals, quality assurance and quality control officers, State Licensing Authorities, haemovigilance experts, and government health officials from Uttar Pradesh, Rajasthan, Uttarakhand, Haryana, Punjab, and Madhya Pradesh.

The inaugural session was addressed by Harsh Mangla, Joint Secretary (Drug and Food Regulation), Department of Health and Family Welfare, Government of India, virtually. He appreciated IPC's efforts in introducing pharmacopoeial standards for blood and blood components in IP 2026 (exclusively), not present in any other pharmacopoeia. He also motivated all stakeholders to work collectively in moving forward to our shared commitment of ensuring the quality, safety, and availability of blood and blood components to strengthen healthcare delivery and safeguard patient welfare.

Dr. G. N. Singh, Advisor to the Chief Minister of Uttar Pradesh and Former Secretary-cum-Scientific Director, IPC, also graced the inaugural session.  The programme commenced with a welcome address by Dr. Jai Prakash, Senior Principal Scientific Officer, IPC, followed by introductory remarks from Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC.

Addressing the participants, Dr. V. Kalaiselvan highlighted the significance of the newly incorporated standards for blood and blood components in IP 2026, emphasizing their role in strengthening quality assurance, patient safety, and regulatory compliance in transfusion services. He noted that the standards are aligned with contemporary scientific developments and national and international regulatory requirements.

The conference featured technical sessions on IP 2026 standards for blood and blood components, regulatory requirements, rational use of blood, plasma quality, the National Formulary of India (NFI), the Haemovigilance Programme of India (HvPI), and IP Online. A panel discussion involving experts from IPC, State Licensing Authorities, HvPI, and transfusion medicine institutions deliberated on implementation strategies and emerging regulatory expectations.

The conference served as a platform for stakeholder engagement and capacity building, enabling blood centres to prepare for the effective adoption of IP 2026 standards. Participants reaffirmed their commitment to implementing the updated standards to further enhance the quality, safety, and efficacy of blood and blood components across the country.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.